ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,090 | -44.0% | 8,027 | -37.2% | 0.00% | -50.0% |
| Q2 2023 | $366,559 | +164.0% | 12,781 | +120.6% | 0.00% | +100.0% |
| Q1 2023 | $138,858 | +41.3% | 5,793 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $98,249 | +34.6% | 5,793 | +18.0% | 0.00% | – |
| Q3 2022 | $73,000 | -6.4% | 4,911 | -0.5% | 0.00% | – |
| Q2 2022 | $78,000 | -44.3% | 4,938 | -5.0% | 0.00% | -100.0% |
| Q1 2022 | $140,000 | -27.5% | 5,200 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $193,000 | -22.8% | 5,226 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $250,000 | +39.7% | 5,225 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $179,000 | -16.0% | 5,277 | +2.3% | 0.00% | 0.0% |
| Q1 2021 | $213,000 | +134.1% | 5,160 | +145.8% | 0.00% | 0.0% |
| Q4 2020 | $91,000 | +23.0% | 2,099 | +21.9% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | +100.0% | 1,722 | +119.1% | 0.00% | – |
| Q2 2020 | $37,000 | – | 786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |